Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Our Journals
    • Journal content
    • Journal articles

    Follow us on social media

  • News
  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Features
    • The week in cell therapy
      • Spotlights
      • In Focus
      • Tech digest
    • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
    • Find a partner
      • Events
      • Events coverage
      • The Glossary for Advanced Therapies

    Follow us on social media

  • Multimedia
    • eBooks
    • Webinars
    • Podcasts
    • Videos
    • Infographics

    Follow us on social media

  • Register
Spotlight exclusive: Expert insights on GMP media, xeno-free solutions and raw material management Read the interview!

Welcome to RegMedNet

4 JUN 2026 STEM CELLS
Exploring MSC-derived exosomes for tissue repair and regeneration
4 JUN 2026 CANCER
Cell therapy weekly: FDA draft guidance to help accelerate cell and gene therapies
29 MAY 2026 CLINICAL TRIALS
Macrophage cell therapy demonstrates success in advanced liver disease trial
29 MAY 2026 NEWS
A stretch in science: hydrogel heals injured tendons
29 MAY 2026 INDUSTRY DEVELOPMENTS
Cell therapy weekly: base editing therapy for hypercholesterolemia
27 MAY 2026 DISEASE AREA
Experimental gene therapy boosts neuron resilience to neurodegeneration
1 / 6

Sign up for our RegMedNet weekly news round-up

14 MAY 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Industry updates with Dusko Ilic: April 2026
12 MAY 2026 CANCER / ARTICLE
AAV-ancing gene therapies
30 APR 2026 DISEASE AREA / ARTICLE
Top stem cell-based therapies taking the field by storm

Our Journals Journal Content

Journal Content

29 APR 2026 Research Article / Regenerative Medicine

Factors that influence trust in non-standard stem cell therapies among patients with...

4 MAR 2026 Research Article / Regenerative Medicine

Comparative study of the effects of subcutaneously administered umbilical cord-derived mesenchymal stem...

23 FEB 2026 Review / Regenerative Medicine

Clinical applications of induced pluripotent stem cell-mediated therapies in cancer: progress, challenges,...

1 DEC 2025 Research Article / Regenerative Medicine

Reimbursement routes and past practices for advanced therapy medicinal products in the...

27 NOV 2025 Review / Regenerative Medicine

Three-dimensional bio-printed microtissues: precision medicine approach in primary liver cancer

12 OCT 2025 Research Article / Regenerative Medicine

Comparison of 3D culture systems on mesenchymal stem cell longevity, regenerative potential,...

Featured

6 MAY 2026 IN FOCUS
In Focus: Stem cell therapy
21 APR 2026 REGULATION & POLICY / PODCAST
Harmonizing scientific innovation, patient care and regulation in advanced therapies: a podcast with Patrice Faloye
2 APR 2026 SPOTLIGHT
Spotlight on raw materials and supply chain
19 FEB 2026 GENE THERAPY / PODCAST
Breaking barriers in neurodegenerative disorders with gene therapy: a podcast with Deborah Ojutalayo
10 FEB 2026 TISSUE ENGINEERING OR REPLACEMENTS / PODCAST
Innovating and developing tissue engineering beyond replacement: a podcast with Guillermo Ameer
5 FEB 2026 AWARENESS / PODCAST
Research and progress in sickle cell disease and thalassemia: a podcast with Baba Inusa
28 NOV 2025 SPOTLIGHT
Spotlight on cell therapy sources and clinical applications
15 OCT 2025 IN FOCUS
In Focus: AAV characterization and analysis for gene therapy
25 SEP 2025 IN FOCUS
In Focus: Allogeneic cell therapy
5 AUG 2025 IN FOCUS
In Focus: Supply chain

Must Watch

19 MAR 2026 MSCS / WEBINAR
Bridging gaps in MSC therapy development through strategic partnership
30 JAN 2026 INTERVIEWS / VIDEO
Engineering MSC-derived exosome mimetics for bone regeneration: an interview with Jiabing Fan
28 OCT 2025 CELL THERAPY / WEBINAR
Q&A highlights: Cell manufacturing with GMP ancillary material solutions from BioLegend
12 AUG 2025 CELL THERAPY / WEBINAR
Cell manufacturing with GMP ancillary material solutions from BioLegend
14 MAR 2025 MANUFACTURING & SCALE-UP / WEBINAR
Bridging platforms for enhanced & harmonized bioprocess data collaboration
12 FEB 2025 CELL THERAPY / WEBINAR
From bench to patient care: unlocking iPSC potential through innovative science and strategic partnerships
20 JAN 2025 GENE THERAPY / WEBINAR
USP Standards for plasmid DNA: quality control in cell and gene therapy
Scalable hiPSC production for 3D bioprinting
17 JAN 2025 3D PRINTING / WEBINAR
Four billion cells in four days: a scalable 3D bioprinting success story
raw material quality for cell and gene therapies Regulatory standards in cell and gene therapies Regulatory compliant raw materials
23 SEP 2024 GENE THERAPY / WEBINAR
Decoding raw material quality and regulatory standards in cell and gene therapy
Cell and gene therapy manufacturing Cell therapy quality challenges GMP manufacturing of quality ancillary reagents for cell and gene therapy
23 JUL 2024 CELL THERAPY / WEBINAR
GMP manufacturing of quality ancillary reagents for cell and gene therapy

What's Trending?

12 MAY 2026 CELL THERAPY / ARTICLE
Addressing supply chain challenges: Expert insights on GMP media, xeno-free solutions and raw material management
15 MAY 2026 MSCS / ARTICLE
A new clinical trial assessing mesenchymal stem cells in mild Alzheimer’s
29 MAY 2026 INDUSTRY DEVELOPMENTS / ARTICLE
Cell therapy weekly: base editing therapy for hypercholesterolemia
26 MAY 2026 AWARENESS / ARTICLE
World MS Day 2026: emerging regenerative medicines
7 MAY 2026 INTERVIEWS / ARTICLE
Laying the foundations for a robust stem cell workflow
6 MAY 2026 IN FOCUS
In Focus: Stem cell therapy
  • About
  • Contact Us
  • Advertising & Sponsorship
  • Expert Panel
  • The Glossary for Advanced Therapies
  • Permissions & content ownership policy
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

RegMedNet is powered by Taylor & Francis Group

RegMedNet, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 RegMedNet